What is Venous Thromboembolism (VTE)? Symptoms and various treatments available in market?

 


Venous Thromboembolism (VTE) is a condition caused by a blocked or narrowed vein. It happens when a blood vessel in the leg becomes narrowed or blocked, because of years of wear and tear. The most common causes of venous thromboembolism include cancer, thrombioma, immobilization, and surgery. Deep vein thrombosis (DVT) forms in the lower legs when the flow of blood is altered or slowed by something.

Older people are more prone to venous thromboembolism because their veins are weaker and may not respond to medication as effectively as younger people. Also, because older people have decreased blood clotting ability, they are much more likely to get blood clots that can cause significant pain, especially around the lower legs. Unchecked venous thromboembolism can lead to heart attacks, pulmonary embolism, or stroke.

People with type 1 diabetes are at an increased risk of developing venous thromboembolism because of the increased risk of poor circulation. For those who do not yet have symptoms of venous thromboembolism, there is an increased risk of getting it if they have slow circulation - even if they do not have type 1 diabetes

Deep vein thrombotic disease, or DVT, occurs when a clot forms in a deep vein. This condition does not happen every time, but there are several factors that increase the risk. The most common factor is poor circulation due to venous insufficiency. Some patients may also develop venous thromboembolism if they have had surgery affecting the veins, such as a hemorrhoidectomy or varicose ulcer. Hemorrhoids, varicose veins, and pregnancy all contribute to a higher risk of developing DVT. Sclerotherapy vein stripping or thrombolytic injection are some of the treatment option available.

Recently, UK-based medical devices company, Sky Medical Technology Ltd, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its geko™ device for stimulation of the calf muscles to prevent venous thrombosis in non-surgical patients at risk for venous thromboembolism (VTE)

Comments

Popular posts from this blog

Increasing Initiatives to Digitalize the Healthcare Sector Is Expected To Boost Demand for Electronic Medical Records

Ureteroscopes are highly preferred option over traditional ureteroscopy

Pharmacy Benefit Management is an Integral Part of the Medicare System